TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Somnomed Limited ( (AU:SOM) ).
Somnomed Limited has announced a change in the director’s interest, with Karen Borg acquiring 1,700,000 options, as approved at the company’s Annual General Meeting. This change reflects an increase in Borg’s stake in the company, potentially signaling confidence in the company’s future performance and strategic direction, which may impact stakeholders’ perceptions and the company’s market positioning.
The most recent analyst rating on (AU:SOM) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Somnomed Limited stock, see the AU:SOM Stock Forecast page.
More about Somnomed Limited
Somnomed Limited operates in the healthcare industry, focusing on providing oral appliance therapy for the treatment of sleep-related breathing disorders, including obstructive sleep apnea. The company is known for its innovative solutions that cater to both patients and healthcare professionals, aiming to improve sleep quality and overall health outcomes.
Average Trading Volume: 373,921
Technical Sentiment Signal: Buy
Current Market Cap: A$176.7M
For a thorough assessment of SOM stock, go to TipRanks’ Stock Analysis page.